Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Int. J. Mol. Sci. 2013, 14(8), 15615-15635; doi:10.3390/ijms140815615
Review

Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer

,
,
 and *
Received: 4 July 2013; in revised form: 14 July 2013 / Accepted: 15 July 2013 / Published: 26 July 2013
(This article belongs to the Special Issue Molecular Research in Urology)
View Full-Text   |   Download PDF [352 KB, uploaded 19 June 2014]   |   Browse Figure
Abstract: In the majority of castration-resistant prostate cancer (CRPC), prostate-specific antigen (PSA), product of a gene that is almost exclusively regulated by the androgen receptor (AR), still acts as a serum marker reflecting disease burden, indicating that AR signaling is activated even under castrate level of serum androgen. Accumulated evidence shows that transcriptional ability of AR is activated both in ligand-dependent and -independent manners in CRPC cells. Some androgen-independent sublines derived from originally androgen-dependent LNCaP prostate cancer cells overexpress the AR and PSA, for which silencing the AR gene suppresses cellular proliferation. The overexpression of the AR confers androgen-independent growth ability on androgen-dependent prostate cancer cells. Some patient-derived prostate cancer xenograft lines also acquire castration-resistant growth ability secreting PSA. More recent publications have shown that the AR activated in CRPC cells regulates distinct gene sets from that in androgen-dependent status. This concept provides very important insights in the development of novel anti-prostate cancer drugs such as new generation anti-androgens and CYP17 inhibitors.
Keywords: prostate cancer; castration resistant; androgen receptor; molecular target prostate cancer; castration resistant; androgen receptor; molecular target
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Kobayashi, T.; Inoue, T.; Kamba, T.; Ogawa, O. Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer. Int. J. Mol. Sci. 2013, 14, 15615-15635.

AMA Style

Kobayashi T, Inoue T, Kamba T, Ogawa O. Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences. 2013; 14(8):15615-15635.

Chicago/Turabian Style

Kobayashi, Takashi; Inoue, Takahiro; Kamba, Tomomi; Ogawa, Osamu. 2013. "Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer." Int. J. Mol. Sci. 14, no. 8: 15615-15635.



Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert